GSA Capital Partners’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-6,809
| Closed | -$323K | – | 1635 |
|
|
2025
Q3 | $323K | Buy |
+6,809
| New | +$330K | 0.03% | 1159 |
|
|
2024
Q2 | – | Sell |
-11,116
| Closed | -$281K | – | 1592 |
|
|
2024
Q1 | $281K | Buy |
+11,116
| New | +$267K | 0.02% | 1254 |
|
|
2023
Q4 | – | Sell |
-20,597
| Closed | -$1.04M | – | 1459 |
|
|
2023
Q3 | $1.04M | Buy |
+20,597
| New | +$959K | 0.09% | 373 |
|
|
2023
Q1 | – | Sell |
-5,106
| Closed | -$280K | – | 1446 |
|
|
2022
Q4 | $280K | Buy |
+5,106
| New | +$219K | 0.03% | 974 |
|
